About US
Contact us
-
Endo revises pain drug recall from 1 to 101 lotsIn September, the generics subsidiary of Endo Health Solutions ($ENDP) voluntarily recalled one lot of two pain drugs that it called "super potent" because both exceeded their prescribed weights. Now2012/12/10
-
NICE snubs Pfizer's Inlyta kidney cancer drugPfizer ($PFE) has run into the U.K. watchdog wall of resistance to targeted cancer drugs with its renal cancer treatment Inlyta. The drugmaker was seeking approval for use in patients with advance2012/12/10
-
Another pharma free speech case hits U.S. appeals courtWhile we're still digesting the news that one U.S. appeals court figures off-label discussions are protected by the First Amendment, another panel is considering a similar argument. The Ninth Circuit2012/12/7
-
U.S. patient sues Ranbaxy over generic Lipitor recallLast month, Ranbaxy Laboratories recalled its version of the cholesterol-fighting pill Lipitor. By last week, the company had stopped making the drug, at least until it can iron out the manufacturing2012/12/7
-
Indian bureaucrats decide to review all foreign pharma investmentsAfter months of bureaucratic debate, the Indian government has decided to require government approval of all foreign investment in domestic pharma companies. The Foreign Investment Promotion Board wi2012/12/6
-
Sartorius Stedim Biotech Launches Sartoguard NF Prefilter SeriesSartorius Stedim Biotech (SSB), a leading international pharma supplier, has launched the Sartoguard NF prefilter series, completing its range of Sartoguard prefilters. These new prefilters feature a2012/12/6
-
Should FDA usher old-style opioid generics onto the market?On one side stand Endo Health Solutions ($ENDP) and Purdue Pharma. On the other, generic drugmakers that want to introduce copies of big-selling, high-powered painkillers. In the middle, the FDA, whi2012/12/5
-
Neopharma to make Merck Serono diabetes drug for Middle EastAs drugmakers search the horizon for new markets where they can get some growth and perhaps get a jump on the competition, the Middle East is looking increasingly attractive. At least Merck Serono thi2012/12/5
-
Health economics and outcomes research 'increasingly important to pharma'Pharmaceutical companies are increasingly setting aside funding for research on health economics and outcomes, a study suggests. Cutting Edge Information's latest report, entitled 'Health Economics a2012/12/4
-
TOT Biopharm opens new production facility in ChinaTOT Biopharm Company Ltd has opened a new factory in eastern China. Stage one of its new high-tech production factory complex in the Suzhou Industrial Park has now been completed, with an inauguration2012/12/4